服务热线
18611095289
GlycoTech公司成立于1991年,如今是专注于糖缀合物的生物功能和医学应用的重要公司之一。公司建立了自主研发项目,并获多项。 GlycoTech通过目录业务建立了罕见碳水化合物试剂库和技术。
GlycoTech与Novartis公司在研发用于防止移植引发的再灌注损伤中淋巴细胞从血流中外渗的强效拮抗剂-碳水化合物配体小分子模拟物-方面已持续合作了六年。另外,GlycoTech公司近授权给Chiron公司,同意其在世界范围内销售使用GlycoTech公司的抗碳水化合物肿瘤标志物的癌症诊断产品。GlycoTech公司还与NIH,宾夕法尼亚大学,罗切斯特大学和芝加哥神经手术和神经研究所建立了研究合作协议。
GlycoTech公司化合物和试剂业务部门的目标是为科学家提供技术和试剂,使碳水化合物研究扩展到细胞生物学,免疫学,神经生物学和分子生物学等其他领域。公司目录的部分包括科学家撰写的涵盖糖生物学主题的实验方法。下一部分包括按照前一部分实验方法就可以使即使不专注于糖生物学的实验室做糖生物学实验的多种特殊的碳水化合物试剂。GlycoTech公司的长远目标是将公司的技术和试剂用于基于糖缀合物和其受体相互作用基础上,发现碳水化合物新生物功能的研究上。
产品类别:癌症诊断产品,人选择蛋白,碳水化合物多聚物,碳水化合物抗体,HAS/BSA缀合物,细胞黏附装置,人内皮细胞,碳水化合物/试剂,碳水化合物吸附剂,实验方法
合成碳水化合物聚和物和探针(Synthetic Carbohydrate Polymers and Probes) | |||
单价生物素化探针(Univalent Biotinylated Probes) | |||
品名 | 货号 | 规格 | |
HOCH2(HOCH)4CH2NH-biotin | 02-000 | 0.5 mg | |
单糖(Monosaccharides) | |||
a-D-Glc-sp-biotin | 02-001 | 1 mg | |
b-D-Glc-sp-biotin | 02-002 | 1 mg | |
a-D-Gal-sp-biotin | 02-003 | 1 mg | |
b-D-Gal-sp-biotin | 02-004 | 1 mg | |
a-D-Man-sp-biotin | 02-005 | 1 mg | |
a-D-Man-6-phosphate-sp-biotin | 02-006 | 1 mg | |
a-L-Fuc-sp-biotin | 02-007 | 1 mg | |
a-L-Rha-sp-biotin | 02-008 | 1 mg | |
b-GlcNAc-sp-biotin | 02-009 | 1 mg | |
a-GalNAc-sp-biotin | 02-010 | 1 mg | |
b-GalNAc-sp-biotin | 02-011 | 1 mg | |
a-Neuc-sp-biotin | 02-012 | 1 mg | |
Neuca2-sp-biotin (sp=-OCH2C6H4-p-NHCOCH2-) | 02-013 | 1 mg | |
Neucb2-sp-biotin (sp=-OCH2C6H4-p-NHCOCH2-) | 02-103 | 1 mg | |
MDP-sp-biotin | 02-014 | 1 mg | |
b-D-Gal-3-sulfate-sp-biotin | 02-015 | 1 mg | |
6-HSO3GlcNAcb-sp-biotin | 02-016 | 1 mg | |
b-D-Man-sp-biotin | 02-050 | 1 mg | |
Neu5Gca-sp-biotin | 02-051 | 1 mg | |
3-HSO3GlcAb-sp-biotin | 02-099 | 1 mg | |
3-HSO3-GalNAcb-sp-biotin | 02-104 | 1 mg | |
双糖(Disaccharides) | |||
Blood type A: GalNAca1-3Galb-sp-biotin | 02-017 | 1 mg | |
Blood type B: Gala1-3Galb-sp-biotin | 02-018 | 1 mg | |
Blood Type H: Fuca1-2Galb-sp-biotin | 02-019 | 1 mg | |
Galb1-3GlcNAcb-sp-biotin (Lec-sp-biotin) | 02-020 | 1 mg | |
Galb1-4Glcb-sp-biotin (Lac-sp-biotin) | 02-021 | 1 mg | |
Galb1-4GlcNAcb-sp-biotin (LacNAc-sp-biotin) | 02-022 | 1 mg | |
Galb1-3GalNAca-sp-biotin | 02-023 | 1 mg | |
Fuca1-3GlcNAcb-sp-biotin | 02-024 | 1 mg | |
Fuca1-3GlcNAcb-sp-biotin | 02-025 | 1 mg | |
GalNAca1-3GalNAcb-sp-biotin | 02-026 | 1 mg | |
GalNAca1-3GalNAca-sp-biotin | 02-027 | 1 mg | |
Gala1-3GalNAca-sp-biotin | 02-028 | 1 mg | |
Galb1-3GalNAcb-sp-biotin | 02-029 | 1 mg | |
Gala1-3GalNAcb-sp-biotin | 02-030 | 1 mg | |
Galb1-3Galb-sp-biotin | 02-031 | 1 mg | |
GlcNAcb1-3Galb1-sp-biotin | 02-052 | 1 mg | |
Gala1-4GlcNAcb-sp-biotin (a-LacNAc-PAA) | 02-053 | 1 mg | |
Glca1-4Glcb-sp-biotin | 02-054 | 1 mg | |
Galb1-3GalNAca-sp-biotin (sp=-p-OC6H4-) | 02-055 | 1 mg | |
Gala1-2Galb-sp-biotin | 02-056 | 1 mg | |
GlcNAcb1-4GlcNAcb-sp-biotin | 02-057 | 1 mg | |
GlcNAcb1-4GlcNAcb-sp-biotin (sp=-NHCOCH2NH-) | 02-058 | 1 mg | |
Neuca2-6GalNAca-sp-biotin | 02-059 | 0.5 mg | |
H(type 3)-sp-biotin | 02-060 | 1 mg | |
3’-HSO3LacNAc-sp-biotin | 02-061 | 1 mg | |
3’-HSO3Galb1-3GlcNAc-sp-biotin | 02-062 | 1 mg | |
Gala1-6Glc-sp-biotin | 02-063 | 1 mg | |
(Neuca2-8)2-sp-biotin | 02-064 | 1 mg | |
Galb1-2Galb-sp-biotin | 02-065 | 1 mg | |
6-HSO3LacNAc-sp-biotin | 02-066 | 1 mg | |
3`-HSO3Galb1-3GalNAca-sp-biotin | 02-069 | 1 mg | |
GalNAcb1-3GalNAcb-sp-biotin | 02-070 | 1 mg | |
GlcNAcb1-3GalNAca-sp-biotin | 02-071 | 1 mg | |
GlcNAcb1-6GalNAca-sp-biotin | 02-072 | 1 mg | |
Neuca2-6Galb-sp-biotin | 02-105 | 0.5 mg | |
Fucb1-3GlcNAcb-sp-biotin | 02-106 | 1 mg | |
Neu5Gca2-6GalNAca-sp-biotin | 02-107 | 0.5 mg | |
Neucb2-6GalNAca-sp-biotin | 02-108 | 0.5 mg | |
Neuca2-3GalNAca-sp-biotin | 02-109 | 0.5 mg | |
三糖(Trisaccharides) | |||
Blood type A (tri)-sp-biotin | 02-032 | 1 mg | |
Blood type A (tri)-sp-biotin, sp=(CH2)3NHCO(CH2)5NH- | 02-084 | 1 mg | |
Blood type B (tri)-sp-biotin | 02-033 | 1 mg | |
Blood type B (tri)-sp-biotin, sp=(CH2)3NHCO(CH2)5NH- | 02-085 | 1 mg | |
H(type 2)-sp-biotin | 02-034 | 1 mg | |
Lea-sp-biotin | 02-035 | 1 mg | |
Lex-sp-biotin | 02-036 | 1 mg | |
Led-sp-biotin | 02-037 | 1 mg | |
Neuca2-3Galb1-4Glc-sp-biotin | 02-038 | 0.5 mg | |
Neuca2-6Galb1-4Glc-sp-biotin | 02-039 | 0.5 mg | |
3’-HSO3Lea-sp-biotin | 02-040 | 0.5 mg | |
3’-HSO3Lex-sp-biotin | 02-041 | 0.5 mg | |
Galb1-4Galb1-4Glcb-sp-biotin | 02-073 | 1 mg | |
GalNAcb1-4Galb1-4Glcb-sp-biotin | 02-074 | 1 mg | |
Gala1-3Galb1-4Glc-sp-biotin | 02-075 | 1 mg | |
GlcNAcb1-2Galb1-3GalNAca-sp-biotin | 02-076 | 1 mg | |
Neuca2-3Galb1-4GlcNAcb-sp-biotin | 02-077 | 0.5 mg | |
Neuca2-3Galb1-3GlcNAc-sp-biotin | 02-078 | 0.5 mg | |
Gala1-3Galb1-4GlcNAc-sp-biotin | 02-079 | 1 mg | |
GlcNAca1-3Galb1-3GalNAca-sp-biotin | 02-080 | 1 mg | |
(Neuca2-8)3-sp-biotin | 02-081 | 1 mg | |
GlcNAcb1-3Galb1-3GalNAca-sp-biotin | 02-082 | 1 mg | |
GlcNAcb1-6(Galb1-3)GalNAca-sp-biotin | 02-083 | 1 mg | |
GlcNAcb1-3Galb1-4Glcb-sp-biotin | 02-087 | 1 mg | |
Neuca2-3Galb1-3GalNAca-sp-biotin | 02-088 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)GalNAca-sp-biotin | 02-089 | 1 mg | |
Mana1-3(Mana1-6)Man-sp-biotin | 02-101 | 1 mg | |
Gala1-4Galb1-4Glcb-sp-biotin | 02-102 | 1 mg | |
Gala1-4Galb1-4GlcNAcb-sp-biotin | 02-110 | 1 mg | |
GlcNAcb1-4(GlcNAcb1-6)GalNAca-sp-biotin | 02-111 | 1 mg | |
GlcNAcb1-4GlcNAcb1-4GlcNAcb-sp-biotin | 02-112 | 1 mg | |
(sp=-NHCOCH2NH-) | |||
Galb1-3(Neuca2-6)GalNAca-sp-biotin | 02-113 | 0.5 mg | |
Galb1-3(Neucb2-6)GalNAca-sp-biotin | 02-114 | 1 mg | |
Neuca2-3(Neuca2-6)GalNAca-sp-biotin | 02-115 | 0.5 mg | |
Galb1-4GlcNAcb1-3GalNAca-sp-biotin | 02-116 | 1 mg | |
Galb1-4GlcNAcb1-6GalNAca-sp-biotin | 02-117 | 1 mg | |
四糖或更多低聚糖(Tetra- or more Oligosaccharides) | |||
Leb-sp-biotin | 02-042 | 1 mg | |
Ley-sp-biotin | 02-043 | 1 mg | |
Sialyl Lea-sp-biotin | 02-044 | 0.5 mg | |
Sialyl Lex-sp-biotin | 02-045 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb1-sp-biotin | 02-090 | 1 mg | |
A(type 2)-sp-biotin | 02-091 | 1 mg | |
B(type 2)-sp-biotin | 02-092 | 1 mg | |
Gala1-3Galb1-4(Fuca1-3)GlcNAcb-sp-biotin | 02-093 | 1 mg | |
6(Gal)-HSO3SiaLex-sp-biotin | 02-094 | 0.25 mg | |
6(GlcNAc)-HSO3SiaLex-sp-biotin | 02-095 | 0.25 mg | |
Galb1-3GlcNAcb1-3Galb1-4Glc-sp-biotin | 02-097 | 0.5 mg | |
Galb1-4GlcNAcb1-3Galb1-4Glc-sp-biotin | 02-098 | 0.5 mg | |
Gala1-3(Gala1-4)Galb1-4GlcNAcb-sp-biotin | 02-118 | 1 mg | |
GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-119 | 1 mg | |
GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-120 | 1 mg | |
Gala1-4(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-121 | 1 mg | |
GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-sp-biotin | 02-122 | 1 mg | |
Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-sp-biotin | 02-123 | 1 mg | |
Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-sp-biotin | 02-124 | 1 mg | |
Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-sp-biotin | 02-125 | 1 mg | |
(SA2-6G-GN-M)2-3,6-M-GN-GNb-sp-biotin | 02-126 | 0.5 mg | |
sp=-NHCOCH2NH- | |||
SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
多价聚合物(M*lent Polymers) | |||
品名 | 货号 | 规格 | |
HOCH2(HOCH)4CH2NH-PAA | 08-000 | 0.5 mg | |
单糖(Monosaccharides) | |||
a-D-Glucose-PAA | 08-001 | 1 mg | |
b-D-Glucose-PAA | 08-002 | 1 mg | |
a-D-Galactose-PAA | 08-003 | 1 mg | |
b-D-Galactose-PAA | 08-004 | 1 mg | |
a-D-Mannose-PAA | 08-005 | 1 mg | |
a-D-Man-6-phosphate-PAA | 08-006 | 1 mg | |
a-L-Fucose-PAA | 08-007 | 1 mg | |
a-L-Rhamnose-PAA | 08-008 | 1 mg | |
b-GlcNAc-PAA | 08-009 | 1 mg | |
a-GalNAc-PAA | 08-010 | 1 mg | |
b-GalNAc-PAA | 08-011 | 1 mg | |
a-Neuc-PAA | 08-012 | 1 mg | |
a-Neuc-OCH2C6H4-p-NHCOCH2-PAA | 08-013 | 1 mg | |
MDP-PAA | 08-014 | 1 mg | |
b-D-Gal-3-sulfate-PAA | 08-015 | 1 mg | |
b-D-GlcNAc-6-sulfate-PAA | 08-016 | 1 mg | |
b-D-Man-PAA | 08-050 | 1 mg | |
Neu5Gca-PAA | 08-051 | 1 mg | |
3-HSO3-GalNAcb-PAA | 08-104 | 1 mg | |
双糖(Disaccharides) | |||
Blood type A: GalNAca1-3Galb-PAA | 08-017 | 1 mg | |
Blood type B: Gala1-3Galb-PAA | 08-018 | 1 mg | |
Blood type H: Fuca1-2Galb-PAA | 08-019 | 1 mg | |
Galb1-3GlcNAcb-PAA (Lec-PAA) | 08-020 | 1 mg | |
Galb1-4Glcb-PAA (Lac-PAA) | 08-021 | 1 mg | |
Galb1-4GlcNAcb-PAA (LacNAc-PAA) | 08-022 | 1 mg | |
Galb1-3GalNAca-PAA | 08-023 | 1 mg | |
Fuca1-3GlcNAcb-PAA | 08-024 | 1 mg | |
Fuca1-4GlcNAcb-PAA | 08-025 | 1 mg | |
GalNAca1-3GalNAcb-PAA | 08-026 | 1 mg | |
GalNAca1-3GalNAca-PAA | 08-027 | 1 mg | |
Gala1-3GalNAca-PAA | 08-028 | 1 mg | |
Galb1-3GalNAcb-PAA | 08-029 | 1 mg | |
Gala1-3GalNAcb-PAA | 08-030 | 1 mg | |
Galb1-3Galb-PAA | 08-031 | 1 mg | |
GlcNAcb1-3Galb-PAA | 08-052 | 1 mg | |
Gala1-4GlcNAcb-PAA, (a-LacNAc-PAA) | 08-053 | 1 mg | |
Glca1-4Glcb-PAA (maltose) | 08-054 | 1 mg | |
Galb1-3GalNAca-PAA, sp=-p-OC6H4- | 08-055 | 1 mg | |
Gala1-2Galb-PAA | 08-056 | 1 mg | |
GlcNAcb1-4GlcNAcb-PAA | 08-057 | 1 mg | |
GlcNAcb1-4GlcNAcb-PAA, sp=-NHCOCH2NH- | 08-058 | 1 mg | |
Neuca2-6GalNAca-PAA | 08-059 | 0.5 mg | |
H(type 3)-PAA | 08-060 | 1 mg | |
3`-HSO3LacNAc-PAA | 08-061 | 1 mg | |
3`-HSO3Galb-3GlcNAcb-PAA | 08-062 | 1 mg | |
Gala1-6Glcb-PAA (melibiose) | 08-063 | 1 mg | |
Neuca2-8Neuca-sp**-PAA, (Neuc)2 | 08-064 | 1 mg | |
Galb1-2Galb-PAA | 08-065 | 1 mg | |
6-HSO3Galb1-4GlcNAcb-PAA | 08-066 | 1 mg | |
Neuca2-3Gal-PAA | 08-067 | 1 mg | |
6`-HSO3Galb1-4GlcNAcb-PAA | 08-068 | 1 mg | |
3`-HSO3Galb1-3GalNAca-PAA | 08-069 | 1 mg | |
GalNAcb1-3GalNAcb-PAA | 08-070 | 1 mg | |
GlcNAcb1-3GalNAca-PAA | 08-071 | 1 mg | |
GlcNAcb1-6GalNAca-PAA | 08-072 | 1 mg | |
Neuca2-6Galb-PAA | 08-105 | 0.5 mg | |
Fucb1-3GlcNAcb-PAA | 08-106 | 1 mg | |
Neu5Gca2-6GalNAca-PAA | 08-107 | 0.5 mg | |
Neucb2-6GalNAca-PAA | 08-108 | 0.5 mg | |
Neuca2-3GalNAca-PAA | 08-109 | 0.5 mg | |
三糖(Trisaccharides) | |||
Blood type A (tri)-PAA | 08-032 | 1 mg | |
Blood type A (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-084 | 1 mg | |
Blood type B (tri)-PAA | 08-033 | 1 mg | |
Blood type B (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-085 | 1 mg | |
H (type 2)-PAA | 08-034 | 1 mg | |
Lea-PAA | 08-035 | 1 mg | |
Lex-PAA | 08-036 | 1 mg | |
Led (H type 1)-PAA | 08-037 | 1 mg | |
3’-Sialyllactose-PAA | 08-038 | 0.5 mg | |
6’-Sialyllactose-PAA | 08-039 | 0.5 mg | |
3’-HSO3Lea-PAA | 08-040 | 0.5 mg | |
3’-HSO3Lex-PAA | 08-041 | 0.5 mg | |
Galb1-4Galb1-4Glcb-PAA | 08-073 | 1 mg | |
GalNAcb1-4Galb1-4Glcb-PAA | 08-074 | 1 mg | |
Gala1-3Galb1-4Glcb-PAA | 08-075 | 1 mg | |
GlcNAcb1-2Galb1-3GalNAca-PAA | 08-076 | 1 mg | |
Neuca2-3Galb1-4GlcNAcb-PAA | 08-077 | 0.5 mg | |
3`SiaLec-PAA | 08-078 | 0.5 mg | |
Gala1-3Galb1-4GlcNAcb-PAA | 08-079 | 1 mg | |
GlcNAca1-3Galb1-3GalNAca-PAA | 08-080 | 1 mg | |
Neuca2-8Neuca2-8Neuca-sp**-PAA, (Neuc)3 | 08-081 | 1 mg | |
GlcNAcb1-3Galb1-3GalNAca-PAA | 08-082 | 1 mg | |
Galb1-3(GlcNAcb1-6)GalNAca-PAA | 08-083 | 1 mg | |
GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-086 | 1 mg | |
GlcNAcb1-3Galb1-4Glcb-PAA | 08-087 | 1 mg | |
Neuca2-3Galb1-3GalNAca-PAA | 08-088 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA | 08-089 | 1 mg | |
Gala1-4Galb1-4GlcNAcb-PAA | 08-110 | 1 mg | |
GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA | 08-111 | 1 mg | |
GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA | 08-112 | 1 mg | |
(sp=-NHCOCH2NH-) | |||
Galb1-3(Neuca2-6)GalNAca-PAA | 08-113 | 0.5 mg | |
Galb1-3(Neucb2-6)GalNAca-PAA | 08-114 | 0.5 mg | |
Neuca2-3(Neuca2-6)GalNAca-PAA | 08-115 | 0.5 mg | |
Galb1-4GlcNAcb1-3GalNAca-PAA | 08-116 | 1 mg | |
Galb1-4GlcNAcb1-6GalNAca-PAA | 08-117 | 1 mg | |
四糖或更多低聚糖(Tetra- and more Oligosaccharides) | |||
Leb-PAA | 08-042 | 1 mg | |
Ley-PAA | 08-043 | 1 mg | |
Sialyl Lea-PAA | 08-044 | 0.5 mg | |
Sialyl Lex-PAA | 08-045 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)Gal?font FACE="Times New Roman" COLOR="#000000" size="3">1-4Glcb-PAA | 08-090 | 1 mg | |
GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-091 | 1 mg | |
Gala1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-092 | 1 mg | |
Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA | 08-093 | 1 mg | |
Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA (6Gal-HSO3-SiaLex) | 08-094 | 0.25 mg | |
Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA (6GlcNAc-HSO3-SiaLex) | 08-095 | 0.25 mg | |
Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-096 | 0.5 mg | |
Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA | 08-097 | 0.5 mg | |
Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA | 08-098 | 0.5 mg | |
(Neuc)5-6-sp-PAA | 08-100 | 1 mg | |
Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA | 08-118 | 1 mg | |
GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-119 | 1 mg | |
GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-120 | 1 mg | |
Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-121 | 1 mg | |
GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA | 08-122 | 1 mg | |
Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA | 08-123 | 1 mg | |
Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA | 08-124 | 1 mg | |
Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA | 08-125 | 1 mg | |
(SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA | 08-126 | 0.5 mg | |
sp=-NHCOCH2NH- | |||
SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
多价生物素化聚合物(M*lent Biotinylated Polymers) | |||
品名 | 货号 | 规格 | |
HOCH2(HOCH)4CH2NH-PAA-biotin | 01-000 | 0.5 mg | |
单糖(Monosaccharides) | |||
a-D-Glucose-PAA-biotin | 01-001 | 1 mg | |
b-D-Glucose-PAA-biotin | 01-002 | 1 mg | |
a-D-Galactose-PAA-biotin | 01-003 | 1 mg | |
b-D-Galactose-PAA-biotin | 01-004 | 1 mg | |
a-D-Mannose-PAA-biotin | 01-005 | 1 mg | |
a-D-Man-6-phosphate-PAA-biotin | 01-006 | 1 mg | |
a-L-Fucose-PAA-biotin | 01-007 | 1 mg | |
a-L-Rhamnose-PAA-biotin | 01-008 | 1 mg | |
b-GlcNAc-PAA-biotin | 01-009 | 1 mg | |
a-GalNAc-PAA-biotin | 01-010 | 1 mg | |
b-GalNAc-PAA-biotin | 01-011 | 1 mg | |
a-Neuc-PAA-biotin | 01-012 | 1 mg | |
a-Neuc-OCH2C6H4-p-NHCOOCH2-PAA-biotin | 01-013 | 1 mg | |
MDP-PAA-biotin | 01-014 | 1 mg | |
b-D-Gal-3-sulfate-PAA-biotin | 01-015 | 1 mg | |
b-D-GlcNAc-6-sulfate-PAA-biotin | 01-016 | 1 mg | |
b-D-Man-PAA-biotin | 01-050 | 1 mg | |
Neu5Gca-PAA-biotin | 01-051 | 1 mg | |
3-HSO3-GalNAcb-PAA-biotin | 01-104 | 1 mg | |
双糖(Disaccharides) | |||
Blood type A: GalNAca1-3Galb-PAA-biotin | 01-017 | 1 mg | |
Blood type B: Gala1-3Galb-PAA-biotin | 01-018 | 1 mg | |
Blood type H: Fuca1-2Galb-PAA-biotin | 01-019 | 1 mg | |
Galb1-3GlcNAcb-PAA-biotin (Lec-PAA-biotin) | 01-020 | 1 mg | |
Galb1-4Glcb-PAA-biotin (Lac-PAA-biotin) | 01-021 | 1 mg | |
Galb1-4GlcNAcb-PAA-biotin (LacNAc-PAA-biotin) | 01-022 | 1 mg | |
Galb1-3GalNAca-PAA-biotin | 01-023 | 1 mg | |
Fuca1-3GlcNAcb-PAA-biotin | 01-024 | 1 mg | |
Fuca1-4GlcNAcb-PAA-biotin | 01-025 | 1 mg | |
GalNAca1-3GalNAcb-PAA-biotin | 01-026 | 1 mg | |
GalNAca1-3GalNAca-PAA-biotin | 01-027 | 1 mg | |
Gala1-3GalNAca-PAA-biotin | 01-028 | 1 mg | |
Galb1-3GalNAcb-PAA-biotin | 01-029 | 1 mg | |
Gala1-3GalNAcb-PAA-biotin | 01-030 | 1 mg | |
Galb1-3Galb-PAA-biotin | 01-031 | 1 mg | |
GlcNAcb1-3Galb-PAA-biotin | 01-052 | 1 mg | |
Gala1-4GlcNAcb-PAA-biotin, (a-LacNAc-PAA-biotin) | 01-053 | 1 mg | |
Glca1-4Glcb-PAA-biotin (maltose) | 01-054 | 1 mg | |
Galb1-3GalNAca-PAA-biotin, sp=-p-OC6H4- | 01-055 | 1 mg | |
Gala1-2Galb-PAA-biotin | 01-056 | 1 mg | |
GlcNAcb1-4GlcNAcb-PAA-biotin | 01-057 | 1 mg | |
GlcNAcb1-4GlcNAcb-PAA-biotin, sp=-NHCOCH2NH- | 01-058 | 1 mg | |
Neuca2-6GalNAca-PAA-biotin | 01-059 | 0.5 mg | |
H(type 3)-PAA-biotin | 01-060 | 1 mg | |
3`-HSO3LacNAc-PAA-biotin | 01-061 | 1 mg | |
3-HSO3Galb-3GlcNAcb-PAA-biotin | 01-062 | 1 mg | |
Gala1-6Glcb-PAA-biotin (melibiose) | 01-063 | 1 mg | |
Neuca2-8Neuca-sp**-PAA-biotin, (Neuc)2 | 01-064 | 1 mg | |
Galb1-2Galb-PAA-biotin | 01-065 | 1 mg | |
6-HSO3Galb1-4GlcNAcb-PAA-biotin | 01-066 | 1 mg | |
Neuca2-3Gal-PAA-biotin | 01-067 | 1 mg | |
6`-HSO3LacNAc-PAA-biotin | 01-068 | 1 mg | |
3`-HSO3TF-PAA-biotin | 01-069 | 1 mg | |
GalNAcb1-3GalNAcb-PAA-biotin | 01-070 | 1 mg | |
GlcNAcb1-3GalNAca-PAA-biotin | 01-071 | 1 mg | |
GlcNAcb1-6GalNAca-PAA-biotin | 01-072 | 1 mg | |
Neuca2-6Galb-PAA-biotin | 01-105 | 0.5 mg | |
Fucb1-3GlcNAcb-PAA-biotin | 01-106 | 1 mg | |
Neu5Gca2-6GalNAca-PAA-biotin | 01-107 | 0.5 mg | |
Neucb2-6GalNAca-PAA-biotin | 01-108 | 0.5 mg | |
Neuca2-3GalNAca-PAA-biotin | 01-109 | 0.5 mg | |
三糖(Trisaccharides) | |||
Blood type A (tri)-PAA-biotin | 01-032 | 1 mg | |
Blood type A (tri)-PAA-biotin, sp=(CH2)3NHCO(CH2)5NH- | 01-084 | 1 mg | |
Blood type B (tri)-PAA-biotin | 01-033 | 1 mg | |
Blood type B (tri)-PAA-biotin, sp=(CH2)3NHCO(CH2)5NH- | 01-085 | 1 mg | |
H (type 2)-PAA-biotin | 01-034 | 1 mg | |
Lea-PAA-biotin | 01-035 | 1 mg | |
Lex-PAA-biotin | 01-036 | 1 mg | |
Led (H type 1)-PAA-biotin | 01-037 | 1 mg | |
3’-Sialyllactose-PAA-biotin | 01-038 | 0.5 mg | |
6’-Sialyllactose-PAA-biotin | 01-039 | 0.5 mg | |
3’HSO3Lea-PAA-biotin | 01-040 | 0.5 mg | |
3’HSO3Lex-PAA-biotin | 01-041 | 0.5 mg | |
Galb1-4Galb1-4Glcb-PAA-biotin | 01-073 | 1 mg | |
GalNAcb1-4Galb1-4Glcb-PAA-biotin | 01-074 | 1 mg | |
Gala1-3Galb1-4Glcb-PAA-biotin | 01-075 | 1 mg | |
GlcNAcb1-2Galb1-3GalNAca-PAA-biotin | 01-076 | 1 mg | |
Neuca2-3Galb1-4GlcNAcb-PAA-biotin | 01-077 | 0.5 mg | |
3`SiaLec-PAA-biotin | 01-078 | 0.5 mg | |
Gala1-3Galb1-4GlcNAcb-PAA-biotin, sp=-NHCOCH2NH- | 01-079 | 1 mg | |
GlcNAca1-3Galb1-3GalNAca-PAA-biotin | 01-080 | 1 mg | |
Neuca2-8Neuca2-8Neuca-sp**-PAA-biotin, (Neuc)3 | 01-081 | 1 mg | |
GlcNAcb1-3Galb1-3GalNAca-PAA-biotin | 01-082 | 1 mg | |
Galb1-3(GlcNAcb1-6)GalNAca-PAA-biotin | 01-083 | 1 mg | |
GlcNAcb1-3Galb1-4GlcNAcb-PAA-biotin | 01-086 | 1 mg | |
GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-087 | 1 mg | |
Neuca2-3Galb1-3GalNAca-PAA-biotin | 01-088 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA-biotin | 01-089 | 1 mg | |
Gala1-4Galb1-4GlcNAcb-PAA-biotin | 01-110 | 1 mg | |
GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA-biotin | 01-111 | 1 mg | |
GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA-biotin | 01-112 | 1 mg | |
(sp=-NHCOCH2NH-) | |||
Galb1-3(Neuca2-6)GalNAca-PAA-biotin | 01-113 | 0.5 mg | |
Galb1-3(Neucb2-6)GalNAca-PAA-biotin | 01-114 | 0.5 mg | |
Neuca2-3(Neuca2-6)GalNAca-PAA-biotin | 01-115 | 0.5 mg | |
Galb1-4GlcNAcb1-3GalNAca-PAA-biotin | 01-116 | 1 mg | |
Galb1-4GlcNAcb1-6GalNAca-PAA-biotin | 01-117 | 1 mg | |
四糖或更多低聚糖(Tetra- and more Oligosaccharides) | |||
Leb-PAA-biotin | 01-042 | 1 mg | |
Ley-PAA-biotin | 01-043 | 1 mg | |
Sialyl Lea-PAA-biotin | 01-044 | 0.5 mg | |
Sialyl Lex-PAA-biotin | 01-045 | 0.5 mg | |
GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb-PAA-biotin | 01-090 | 1 mg | |
GalNAca1-3(Fuca1-2)Galb1-4GlcNAc-PAA-biotin | 01-091 | 1 mg | |
Gala1-3(Fuca1-2)Galb1-4GlcNAc-PAA-biotin | 01-092 | 1 mg | |
Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA-biotin | 01-093 | 1 mg | |
Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA-biotin (6Gal-HSO3-SiaLex) | 01-094 | 0.25 mg | |
Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA-biotin (6GlcNAc-HSO3-SiaLex) | 01-095 | 0.25 mg | |
Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA-biotin | 01-096 | 0.5 mg | |
Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-097 | 0.5 mg | |
Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-098 | 0.5 mg | |
(Neuc)5-6-sp-PAA-biotin | 01-100 | 1.0 mg | |
Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA-biotin | 01-118 | 1 mg | |
GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-119 | 1 mg | |
GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-120 | 1 mg | |
Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-121 | 1 mg | |
GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA-biotin | 01-122 | 1 mg | |
Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-biotin | 01-123 | 1 mg | |
Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA-biotin | 01-124 | 1 mg | |
Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-biotin | 01-125 | 1 mg | |
(SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA-biotin | 01-126 | 0.5 mg | |
sp=-NHCOCH2NH- | |||
SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
成套的碳水化合物聚和物(Sets of Carbohydrate Polymers) | |||
品名 | 货号 | 规格 | |
ß-GlcNAc-PAA SET | 05-001 | 3x1 mg | |
3’-HSO3Gal-PAA SET | 05-002 | 3x1 mg | |
Blood type A: GalNAc1-3Galß-PAA SET | 05-003 | 3x1 mg | |
Blood type B: Gal1-3Galß-PAA SET | 05-004 | 3x1 mg | |
Blood type O: Fuc1-2Galß-PAA SET | 05-005 | 3x1 mg | |
Blood type A (tri)-PAA SET | 05-006 | 6x1 mg | |
Blood type B (tri)-PAA SET | 05-007 | 6x1 mg | |
Lea-PAA SET | 05-008 | 3x0.1 mg | |
Lex-PAA SET | 05-009 | 3x0.1 mg | |
3’-HSO3Lea-PAA SET | 05-010 | 3x0.1 mg | |
3’-HSO3Lex-PAA SET | 05-011 | 3x0.1 mg | |
Leb-PAA SET | 05-012 | 3x0.1 mg | |
Ley-PAA SET | 05-013 | 3x0.1 mg | |
Sialyl Lea-PAA SET | 05-014 | 5x0.1 mg | |
Sialyl Lex-PAA SET | 05-015 | 5x0.1 mg | |
Lac-PAA SET | 05-016 | 3x1 mg | |
多价荧光素化聚合物(M*lent Fluoresceinated Polymers) | |||
品名 | 货号 | 规格 | |
HOCH2(HOCH)4CH2NH-PAA-fluor. | 03-000 | 0.4 mg | |
单糖(Monosaccharides) | |||
a-D-Glucose-PAA-fluor. | 03-001 | 0.4 mg | |
b-D-Glucose-PAA-fluor. | 03-002 | 0.4 mg | |
a-D-Galactose-PAA-fluor. | 03-003 | 0.4 mg | |
b-D-Galactose-PAA-fluor | 03-004 | 0.4 mg | |
a-D-Mannose-PAA-fluor. | 03-005 | 0.4 mg | |
a-D-Man-6-phosphate-PAA-fluor. | 03-006 | 0.4 mg | |
a-L-Fucose-PAA-fluor. | 03-007 | 0.4 mg | |
a-L-Rhamnose-PAA-fluor. | 03-008 | 0.4 mg | |
b-GlcNAc-PAA-fluor. | 03-009 | 0.4 mg | |
a-GalNAc-PAA-fluor. | 03-010 | 0.4 mg | |
b-GalNAc-PAA-fluor. | 03-011 | 0.4 mg | |
a-Neuc-PAA-fluor. | 03-012 | 0.4 mg | |
a-Neuc-OCH2C6H4-p-NHCOOCH2-PAA-fluor. | 03-013 | 0.4 mg | |
MDP-PAA-fluor. | 03-014 | 0.4 mg | |
b-D-Gal-3-sulfate-PAA-fluor. | 03-015 | 0.4 mg | |
b-D-GlcNAc-6-sulfate-PAA-fluor. | 03-016 | 0.4 mg | |
b-D-Man-PAA-fluor. | 03-050 | 0.4 mg | |
Neu5Gca-PAA-fluor. | 03-051 | 0.4 mg | |
3-HSO3-GalNAcb-PAA-fluor. | 03-104 | 0.4 mg | |
双糖(Disaccharides) | |||
Blood type A: GalNAca1-3Galb-PAA-fluor. | 03-017 | 0.4 mg | |
Blood type B: Gala1-3Galb-PAA-fluor. | 03-018 | 0.4 mg | |
Blood type H: Fuca1-2Galb-PAA-fluor. | 03-019 | 0.4 mg | |
Galb1-3GlcNAcb-PAA-fluor. (Lec-PAA-fluor.) | 03-020 | 0.4 mg | |
Galb1-4Glcb-PAA-fluor. (Lac-PAA-fluor.) | 03-021 | 0.4 mg | |
Galb1-4GlcNAcb-PAA-fluor. (LacNAc-PAA-flour.) | 03-022 | 0.4 mg | |
Galb1-3GalNAca-PAA-fluor. | 03-023 | 0.4 mg | |
Fuca1-3GlcNAcb-PAA-fluor. | 03-024 | 0.4 mg | |
Fuca1-4GlcNAcb-PAA-fluor. | 03-025 | 0.4 mg | |
GalNAca1-3GalNAcb-PAA-fluor. | 03-026 | 0.4 mg | |
GalNAca1-3GalNAca-PAA-fluor. | 03-027 | 0.4 mg | |
Gala1-3GalNAca-PAA-fluor. | 03-028 | 0.4 mg | |
Galb1-3GalNAcb-PAA-fluor. | 03-029 | 0.4 mg | |
Gala1-3GalNAcb-PAA-fluor. | 03-030 | 0.4 mg | |
Galb1-3Galb-PAA-fluor. | 03-031 | 0.4 mg | |
GlcNAcb1-3Galb-PAA-fluor. | 03-052 | 0.4 mg | |
Gala1-4GlcNAcb-PAA-fluor., (a-LacNAc-PAA-fluor.) | 03-053 | 0.4 mg | |
Glca1-4Glcb-PAA-fluor. (maltose) | 03-054 | 0.4 mg | |
Galb1-3GalNAca-PAA-fluor., sp=-p-OC6H4- | 03-055 | 0.4 mg | |
Gala1-2Galb-PAA-fluor. | 03-056 | 0.4 mg | |
GlcNAcb1-4GlcNAcb-PAA-fluor. | 03-057 | 0.4 mg | |
GlcNAcb1-4GlcNAcb-PAA-fluor., sp=-NHCOCH2NH- | 03-058 | 0.4 mg | |
Neuca2-6GalNAca-PAA-fluor. | 03-059 | 0.2 mg | |
H(type 3)-PAA-fluor. | 03-060 | 0.4 mg | |
3`-HSO3LacNAc-PAA-fluor. | 03-061 | 0.4 mg | |
3`-HSO3Galb-3GlcNAcb-PAA-fluor. | 03-062 | 0.4 mg | |
Gala1-6Glcb-PAA-fluor. (melibiose) | 03-063 | 0.4 mg | |
Neuca2-8Neuca-sp**-PAA-fluor., (Neuc)2 | 03-064 | 0.4 mg | |
Galb1-2Galb-PAA-fluor. | 03-065 | 0.4 mg | |
6-HSO3Galb1-4GlcNAcb-PAA-fluor. | 03-066 | 0.4 mg | |
Neuca2-3Gal-PAA-fluor. | 03-067 | 0.4 mg | |
6`-HSO3LacNAc-PAA-fluor. | 03-068 | 0.4 mg | |
3`-HSO3Galb1-3GalNAca-PAA-fluor. | 03-069 | 0.4 mg | |
GalNAcb1-3GalNAcb-PAA-fluor. | 03-070 | 0.4 mg | |
GlcNAcb1-3GalNAca-PAA-fluor. | 03-071 | 0.4 mg | |
GlcNAcb1-6GalNAca-PAA-fluor. | 03-072 | 0.4 mg | |
Neuca2-6Galb-PAA-fluor. | 03-105 | 0.2 mg | |
Fucb1-3GlcNAcb-PAA-fluor. | 03-106 | 0.4 mg | |
Neu5Gca2-6GalNAca-PAA-fluor. | 03-107 | 0.2 mg | |
Neucb2-6GalNAca-PAA-fluor. | 03-108 | 0.2 mg | |
Neuca2-3GalNAca-PAA-fluor. | 03-109 | 0.2 mg | |
三糖(Trisaccharides) | |||
Blood type A (tri)-PAA-fluor. | 03-032 | 0.4 mg | |
Blood type A (tri)-PAA-fluor., sp=(CH2)3NHCO(CH2)5NH- | 03-084 | 0.4 mg | |
Blood type B (tri)-PAA-fluor. | 03-033 | 0.4 mg | |
Blood type B (tri)-PAA-fluor., sp=(CH2)3NHCO(CH2)5NH- | 03-085 | 0.4 mg | |
H (type 2)-PAA-fluor. | 03-034 | 0.4 mg | |
Lea-PAA-fluor. | 03-035 | 0.4 mg | |
Lex-PAA-fluor. | 03-036 | 0.4 mg | |
Led (H type 1)-PAA-fluor. | 03-037 | 0.4 mg | |
3’-Sialyllactose-PAA-fluor. | 03-038 | 0.2 mg | |
6’-Sialyllactose-PAA-fluor. | 03-039 | 0.2 mg | |
3’-HSO3Lea-PAA-fluor. | 03-040 | 0.2 mg | |
3’-HSO3Lex-PAA-fluor. | 03-041 | 0.2 mg | |
Galb1-4Galb1-4Glcb-PAA-fluor. | 03-073 | 0.4 mg | |
GalNAcb1-4Galb1-4Glcb-PAA-fluor. | 03-074 | 0.4 mg | |
Gala1-3Galb1-4Glcb-PAA-fluor. | 03-075 | 0.4 mg | |
GlcNAcb1-2Galb1-3GalNAca-PAA-fluor. | 03-076 | 0.4 mg | |
Neuca2-3Galb1-4GlcNAcb-PAA-fluor. | 03-077 | 0.2 mg | |
3`SiaLec-PAA-fluor. | 03-078 | 0.2 mg | |
Gala1-3Galb1-4GlcNAcb-PAA-fluor., sp=-NHCOCH2NH- | 03-079 | 0.4 mg | |
GlcNAca1-3Galb1-3GalNAca-PAA-fluor. | 03-080 | 0.4 mg | |
Neuca2-8Neuca2-8Neuca-sp**-PAA-fluor., (Neuc)3 | 03-081 | 0.4 mg | |
GlcNAcb1-3Galb1-3GalNAca-PAA-fluor. | 03-082 | 0.4 mg | |
Galb1-3(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-083 | 0.4 mg | |
GlcNAcb1-3Galb1-4GlcNAcb-PAA-fluor. | 03-086 | 0.4 mg | |
GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-087 | 0.4 mg | |
Neuca2-3Galb1-3GalNAca-PAA-fluor. | 03-088 | 0.2 mg | |
GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-089 | 0.4 mg | |
Gala1-4Galb1-4GlcNAcb-PAA-fluor. | 03-110 | 0.4 mg | |
GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-111 | 0.4 mg | |
GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA-fluor. | 03-112 | 0.4 mg | |
(sp=-NHCOCH2NH-) | |||
Galb1-3(Neuca2-6)GalNAca-PAA-fluor. | 03-113 | 0.2 mg | |
Galb1-3(Neucb2-6)GalNAca-PAA-fluor. | 03-114 | 0.4 mg | |
Neuca2-3(Neuca2-6)GalNAca-PAA-fluor. | 03-115 | 0.2 mg | |
Galb1-4GlcNAcb1-3GalNAca-PAA-fluor. | 03-116 | 0.4 mg | |
Galb1-4GlcNAcb1-6GalNAca-PAA-fluor. | 03-117 | 0.4 mg | |
四糖或更多低聚糖(Tetra- and more Oligosaccharides) | |||
Leb-PAA-fluor. | 03-042 | 0.4 mg | |
Ley-PAA-fluor. | 03-043 | 0.4 mg | |
Sialyl Lea-PAA-fluor. | 03-044 | 0.2 mg | |
Sialyl Lex-PAA-fluor. | 03-045 | 0.2 mg | |
GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb-PAA-fluor. | 03-090 | 0.4 mg | |
GalNAca1-3(Fuca1-2)Galb1-4GlcNAc-PAA-fluor. | 03-091 | 0.4 mg | |
Gala1-3(Fuca1-2)Galb1-4GlcNAc-PAA-fluor. | 03-092 | 0.4 mg | |
Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA-fluor. | 03-093 | 0.4 mg | |
Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA-fluor. (6Gal-HSO3-SiaLex) | 03-094 | 0.2 mg | |
Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA-fluor. (6GlcNAc-HSO3-SiaLex) | 03-095 | 0.2 mg | |
Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA-fluor. | 03-096 | 0.2 mg | |
Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-097 | 0.2 mg | |
Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-098 | 0.2 mg | |
(Neuc)5-6-sp-PAA-fluor. | 03-100 | 0.4 mg | |
Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA-fluor. | 03-118 | 0.4 mg | |
GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-119 | 0.4 mg | |
GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-120 | 0.4 mg | |
Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-121 | 0.4 mg | |
GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA-fluor. | 03-122 | 0.4 mg | |
Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-fluor. | 03-123 | 0.4 mg | |
Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA-fluor. | 03-124 | 0.4 mg | |
Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-fluor. | 03-125 | 0.4 mg | |
(SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA-fluor. | 03-126 | 0.2 mg | |
sp=-NHCOCH2NH- | |||
SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
亲和电泳用的碳水化合物聚合物(Carbohydrate Polymers for Affinity Electrophoresis) | |||
品名 | 货号 | 规格 | |
Neoglycoconjugates Set Properties: conjugates are able to copolymerise with acrylamide in standard conditions of electrophoretic gel polymerization, thus forming affinity gels. Use: for separation of lectins and anti-carbohydrate antibodies simultaneously on both electrophoretic and affinity principles,in standard conditions, using standard equipment. | 05-100 | 7x5 mg | |
人或牛血清白蛋白碳水化合物缀合物(Human or Bovine Serum Albumin Carbohydrate Conjugates) | |||
APE coupling(图1) | |||
Product Name | 货号 | 规格 | |
Di-Le(x)-APE-BSA | 07-001 | 0.5 mg | |
Di-Le(x)-APE-HSA | 07-002 | 0.5 mg | |
H-type II-APE-HSA | 07-003 | 0.25 mg | |
Gala1-3Galb-APE-HSA | 07-004 | 0.5 mg | |
Le(y)-APE-HSA | 07-005 | 0.5 mg | |
APD coupling(图2) | |||
Product Name | 货号 | 规格 | |
3’Sialyllactose-APD-HSA | 07-006 | 0.5 mg | |
6’Sialyllactose-APD-HSA | 07-007 | 0.5 mg | |
LNF I-APD-HSA | 07-008 | 0.5 mg | |
LNF II-APD-HSA | 07-009 | 0.5 mg | |
LNF III-APD-HSA | 07-010 | 0.5 mg | |
Sia-Le(a)-APD-HSA | 07-011 | 0.25 mg | |
Sia-LNF V-APD-HSA | 07-012 | 0.25 mg | |
Fuc, Sia-LNnH-APD-HSA | 07-013 | 0.25 mg | |
碳水化合物和试剂(Carbohydrates and Reagents) | |||
Complex Carbohydrates | |||
品名 | 货号 | 规格 | |
2’-Fucosyllactose | 00-001 | 1 mg | |
3-Fucosyllactose | 00-002 | 1 mg | |
Lactodifucotetraose (Difucosyllactose) | 00-003 | 1 mg | |
LcOse 4 (LNT) ( Lacto-N-tetraose) | 00-004 | 1 mg | |
IV2Fuc-LcOse4 (LNF I) (Lacto-N-fucopentaose I) | 00-005 | 1 mg | |
(IV2Fuc,III4-LcOse4 ) (LND I) ( Lacto-N-difucohexaose I) Leb hexasaccharide | 00-006 | 1 mg | |
品名 | 货号 | 规格 | |
(III3Fuc-nLcOse4 ) (LNF III) ( Lacto-N-fucopentaose III) Lex-pentasaccharide | 00-007 | 0.5 mg | |
Monofucosyllacto-N-hexaose | 00-008 | 100 µg | |
Difucosyllacto-N-neohexaose | 00-009 | 100 µg | |
Difucosyllacto-N-neohexaose (b) | 00-010 | 100 µg | |
V4Fuc, III3Fuc-LcOse6 (Difucosyl-para-lacto-N-hexaose) | 00-011 | 100 µg | |
Dimeric LexV3Fuc, III3Fuc-LcOse6 (Difucosyl-para-lacto-N-neohexaose) | 00-012 | 100 µg | |
品名 | 货号 | 规格 | |
Trifucosyllacto-N-hexaose | 00-013 | 100 µg | |
Leb-Lex Trifucosyl-para-lacto-N-hexaose (TFpLNH) | 00-014 | 100 µg | |
3’-Sialyllactose | 00-015 | 1 mg | |
6’-Sialyllactose | 00-016 | 1 mg | |
LST a IV3NeuAc-LcOse4 (LS-tetrasaccharide a) (Sialyllacto-N-tetraose a) | 00-017 | 500 µg | |
LST b III6NeuAc-LcOse4 (LS-tetrasaccharide b) (Sialyllacto-Ntetraose b) | 00-018 | 500 µg | |
品名 | 货号 | 规格 | |
Monofucosyl, monosialyllactose (II3NeuAc, I3Fuc-Lac) | 00-019 | 100 µg | |
Sialyl LNF VI IV6NeuAc, I3Fuc-nLcOse6 (Monosialyl, monofucosyllacto-N-neotetraose) | 00-020 | 100 µg | |
Disialyllacto-N-tetraose (IV3NeuAc, III6NeuAc-LcOse4 ) | 00-021 | 1 mg | |
A-pentasaccharide | 00-022 | 100 µg | |
II2Fuc, I3Fuc-iGbOse3 (B-pentasaccharide) | 00-023 | 100 µg | |
Oligomannose-3 (MAN-3) | 00-024 | 100 µg | |
品名 | 货号 | 规格 | |
Oligomannose-5 (MAN-5) | 00-025 | 100 µg | |
Oligomannose-6 (MAN-6) | 00-026 | 100 µg | |
Oligomannose-7D1 (MAN-7D1) | 00-027 | 20 µg | |
Oligomannose-7D2 (MAN-7D2) | 00-028 | 20 µg | |
Oligomannose-7D3(MAN-7D3) | 00-029 | 20 µg | |
Oligomannose-8D1D3 (MAN-8D1D3) | 00-030 | 20 µg | |
品名 | 货号 | 规格 | |
Oligomannose-8D1D2 (MAN 8D1D2) | 00-031 | 20 µg | |
Oligomannose-8D2D3 (MAN-8D2D3) | 00-032 | 20 µg | |
Oligomannose-9 | 00-033 | 100 µg | |
Asialo-biantennary (NA-2) | 00-034 | 100 µg | |
Asialo-biantennary With Core Substituted Fucose (NA2F) | 00-035 | 20 µg | |
Disialyl-biantennary (A2) | 00-036 | 20 µg | |
品名 | 货号 | 规格 | |
Oligomannose-3 Substituted with Fucose and Xylose (M3N2FX) | 00-037 | 20 µg | |
Oligomannose-2(a) (MAN-2a) | 00-038 | NA | |
Oligomannose-4 (MAN-4) | 00-039 | NA | |
Lacto-N-hexaose (LNH) | 00-040 | 0.5 mg | |
Lacto-N-neohexaose (LNnH) | 00-041 | 0.5 mg | |
Monosialyl LNnH | 00-042 | 0.5 mg | |
品名 | 货号 | 规格 | |
Monosialyl, monofucosyl LNnH | 00-043 | 1 mg | |
Disialyl, monofucosyl LNH | 00-044 | 0.5 mg | |
00-045 to 046 (Repeating ß1-4GlcNAc ) | |||
n=1 Chitobiose | 00-045 | 1 mg | |
n=2 Chitotriose | 00-046 | 1 mg | |
n=3 Chitotetraose | 00-047 | 1 mg | |
00-048 to 051 (Repeating 1-4Glc ) | |||
n=2 Maltotriose | 00-048 | 100 mg | |
n=3 Maltotetrarose | 00-049 | 50 mg | |
n=4 Maltopentaose | 00-050 | 50 mg | |
n=5 Maltohexaose | 00-051 | 50 mg | |
Carbohydrate Analogs and Reagents | |||
Glycoamino Acids | |||
品名 | 货号 | 规格 | |
tetra-O-acetyl-Glc-ß-FMOC-Asn | 06-008 | 100 mg | |
tri-O-acetyl-GalNAc-FMOC-Ser | 06-014 | 100 mg | |
Sialic Acid Derivatives | |||
品名 | 货号 | 规格 | |
Neuc-methyl glycoside | 06-022 | 10 mg | |
Neuc-benzyl glycoside | 06-024 | 10 mg | |
Neucß-benzyl glycoside | 06-035 | 10 mg | |
Neuc-methyl glycoside methyl ester | 06-025 | 10 mg | |
Neuc-methyl ester | 06-036 | 10 mg | |
胞壁肽(Muramyl Peptides) | |||
(N-Acetylmuramyl-L-alanyl-D-isoglutamine and derivatives) | |||
品名 | 货号 | 规格 | |
Muramyldipeptide (MDP) | 06-027 | 10 mg | |
MDPß-hexadecyl glycoside | 06-029 | 10 mg | |
乙酰化糖(Acetylated Saccharides) | |||
品名 | 货号 | 规格 | |
α-D Glucose pentaacetate | 06-030 | 1 gm | |
α-D Galactose pentaacetate | 06-032 | 1 gm | |
ß-D Glucosamine pentaacetate | 06-034 | 1 gm | |
配套产品(Supporting Product) | |||
品名 | 货号 | 规格 | |
Polyisobutylmethacrylate beads | 40-006 | 5 gm | |
碳水化合物亲和吸附剂(Carbohydrate Affinity Adsorbents) | |||
品名 | 货号 | 规格 | |
双糖(Disaccharides) | |||
Blood type B: Gala1-3Galb-Adsorbent | 09-018 | 50 ml | |
Galb1-3GalNAca-PAA-Adsorbent | 09-023 | 10 ml | |
GalNAca1-3GalNAcb-Adsorbent | 09-026 | 10 ml | |
三糖(Trisaccharides) | |||
Blood type A (tri)-Adsorbent | 09-032 | 50 ml | |
Blood type B (tri)-Adsorbent | 09-033 | 50 ml | |
GlcNAcb1-2Galb1-3GalNAca-Adsorbent | 09-076 | 50 ml | |
Adsorbents made using SEPHAROSETM chromatography media. SEPHAROSE is a trademark of GE Healthcare companies | |||
抗体(Antibodies) | |||
品名 | 货号 | 规格 | |
Anti-Lex Isotype: IgM (BRA-4F1) | 10-008 | 200 µg | |
Anti-E-selectin Isotype: IgG1 (7A9) | 11-002 | 200 µg | |
Anti-MUC1 Isotype: IgG1 (VU-4H5) | 11-011 | 200 µg | |
肿瘤碳水化合物生物标志物抗体(Antibodies to Carbohydrate Tumor Markers) | |||
品名 | 癌症类型 | 货号 | 规格 |
CA19-9 Isotype: IgG1 (GSLA-2) | 肠胃癌和胰腺癌 | 11-009 | 200 ug |
DUPAN-2 Isotype: IgM (DUPAN-2) | 肠胃癌和胰腺癌 | 11-010 | 200 ug |
Anti-GM3 Isotype: IgG3 (DH2) | 黑色素瘤 | 10-011 | 200 ug |
Anti-Lex Isotype: IgM (BRA-4F1) | 白血病 | 10-008 | 200 ug |
Anti-Extended Lex Isotype: IgG1 (GELF31) | 乳腺癌 | 11-005 | 200 ug |
Anti-Extended sialyl-Lex Isotype: IgM (FH6) | 卵巢癌 | 11-007 | 200 ug |
Anti-Ley Isotype: IgG2a (BR55) | 乳腺癌 | 11-006 | 200 ug |
Anti-Gb3 Isotype: IgM (1A4) | 淋巴瘤 | 11-008 | 200 ug |
细胞黏附装置(Cell Adhesion Apparatus) | |||
平行板流动小室(Parallel Plate Flow Chambers) | Parallel plate flow chambers are used in dynamic studies of cell adhesion under well-defined shear forces. Various gasket sizes allow flexibility in experimental design to operate with limited quantities of cells and/or reagents. (Refer to Protocol 7) | ||
环形流动小室(适用于35mm培养皿)(Circular Flow Chamber (for 35mm tissue culture dishes)) | |||
Circular Flow Chamber Kit, 货号:31-001 (Technical Reference: Improvements to Parallel Plate Flow Chambers to Reduce Reagents and Cellular Requirements, Brown and Larson, BMC Immunology 2001, 2:9) | Flow Chamber Kit Includes: | ||
Two flow decks | |||
(cast acrylic with different inlet/outlet designs) | |||
8 silicon rubber gaskets (two of each size) | |||
Flow Width = 0.25 cm, Thickness = 0.005 in | |||
Flow Width = 0.25 cm, Thickness = 0.010 in | |||
Flow Width = 0.50 cm, Thickness = 0.010 in | |||
Flow Width = 1.00 cm, Thickness = 0.010 in | |||
24 polypropylene tubing connectors (six of each) | |||
Threaded 1/16 in. straight and L-connectors | |||
Male and Female taper luer to 1/16 in. connectors | |||
Silastic™ laboratory tubing (1/16 in. ID x 10 ft.) | |||
Replacement Gaskets and Coverslips for the Circular Flow Chamber | |||
货号:31-002 | Four Gaskets (Flow Width = 0.25 cm, Thickness = 0.005 in) | ||
货号:31-003 | Four Gaskets (Flow Width = 0.25 cm, Thickness = 0.010 in) | ||
货号:31-004 | Four Gaskets (Flow Width = 0.50 cm, Thickness = 0.010 in) | ||
货号:31-005 | Four Gaskets (Flow Width = 1.00 cm, Thickness = 0.010 in) | ||
货号:31-008 | Circular Glass Coverslips (pack of 30, 35 mm, #2) | ||
长方形流动小室(适用于标准显微镜载玻片)(Rectangular Flow Chamber (for standard microscope slide)) | |||
Rectangular Flow Chamber Kit, 货号:31-010 | Flow Chamber Kit Includes: | ||
One flow deck (cast acrylic) | |||
4 silicon rubber gaskets (two of each size) | |||
Flow Width = 1.00 cm, Thickness = 0.005 in | |||
Flow Width = 1.00 cm, Thickness = 0.010 in | |||
24 polypropylene tubing connectors (six of each) | |||
Threaded 1/16 in. straight and L-connectors | |||
Male and Female taper luer to 1/16 in. connectors | |||
Silastic™ laboratory tubing (1/16 in. ID x 10 ft.) | |||
Replacement Gaskets for the Rectangular Flow Chamber | |||
货号:31-011 | Four Gaskets (Flow Width = 1.0 cm, Thickness = 0.005 in) | ||
货号:31-012 | Four Gaskets (Flow Width = 1.0 cm, Thickness = 0.010 in) | ||
静态条件下分析细胞粘附的洗涤小室(WASH CHAMBER for Assaying Cell Adhesion under Static Conditions) | |||
Static Cell Adhesion Wash Chamber, 货号:31-006 | The use of convenient multiwell plates to assay the adhesion of cells to immobilized molecules under static conditions is usually difficult due to the uncontrolled shear forces normally generated while washing the plate. | ||
The Wash Chamber allows the wells of the multiwell plate to be washed by inversion in a liquid-filled environment. Unbound cells are separated from the wells by gravity thereby eliminating shear and the passage of the adherent cells through a liquid/air interface.(Refer to Protocol 8) | |||
用于研究TLC板上细胞黏附的小室(Chamber for Cell Adhesion on TLC Plates) | |||
CELL ADHESION CHAMBER for TLC Plates, 货号:31-007 | Cell surface carbohydrates act as specific recognition molecules for intercellular adhesion among certain cells. | ||
Glycosphingolipids represent a group of cell surface glycoconjugates that are easily separated and analyzed by thin layer chromatography. The cell adhesion chamber was specifically designed to permit the assay of cell adhesion directly on glycosphingolipids separated on thin layer chromatograms. | |||
Cells are centrifuged directly on the TLC plate to form immediate close contact with chromatographed glycosphingolipids. The position of the bound cells corresponds to the Rf value of the glycosphingolipid ligand which may be used for purification and structural characterization of the functional carbohydrate sequence.(Refer to Protocol 9) |